Tuesday, 21 January 2020

Market Survey News

  • Increasing use of therapeutically superior drugs boosts Biobetters Market: PMR Study

    Market Survey |  Analysis | 0 Comment | 04 Jun, 2019

    Increasing usage of therapeutically more effective drugs for the treatment of chronic diseases is expected to drive the growth of biobetters market. Higher efficacy and lower adverse effect...Read more

  • New scheme in China supports local generics manufacturers: GlobalData

    Market Survey |  Analysis | 0 Comment | 07 Jan, 2019

    The Chinese State Medical Insurance Administration introduced a new procurement in a recent round of reforms pilot scheme across 11 major cities to lower drug prices. The scheme will direct...Read more

  • Global Survey illustrates Type 2 Diabetes people undervalue their cardiovascular risk

    Market Survey |  News | 0 Comment | 07 Dec, 2017

    In Abu Dhabi, The International Diabetes Federation (IDF) presented the interim results of the first ever multi-country online survey on CVD risk awareness and knowledge among people living...Read more

  • The Global Pain Index – an insightful survey worldwide

    Market Survey |  News | 0 Comment | 30 Jun, 2017

    85% Singaporeans have suffered from head and body pain, with nearly half (42%) suffering weekly from body pain 1 in 2 suffer in silence, more commonly men (61%) than women (46%); one-thi...Read more

  • APAC market is gaining pace on par with European market

    Market Survey |  Analysis | 0 Comment | 02 Jun, 2017

    Cell banking market is expected to grow at an exponential rate in the coming years owing to the growing demand for biologics. Overall, biologics are slowly taking a major share of the pharm...Read more

  • Ranbaxy retains grip on generics market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Ranbaxy became the first Indian firm to develop a new drug called Synriam for malaria, which is a health menace that claims half a million lives worldwide each year. In 2012, Ranbaxy mana...Read more

  • Novo Nordisk insulin top pharma product in India

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    India, which has the second largest population in the world and is among the top three nations in terms of patient pool, secured revenues of $10.6 billion in 2011 as compared to $10.3 billi...Read more

  • Singapore rides high on biomedical research

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore, a cosmopolitan city state that offers world-class living standards and attracts talent from all over the globe, has maintained its reputation and standard as the top Asian destin...Read more

  • Lupin gets 16 FDA nods, launches 11 products front

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11 products during 2012. Besides building a strong gri...Read more

  • CSL marks a billion dollar in profits

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1...Read more

  • CRO Survey 2014: CRO Landscape across APAC

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2014

    Singapore: Asia has earned the status of a fast growing market for clinical research due to its diverse population, faster recruitment of patients and operational costs which are lower by 3...Read more

  • Cipla keeps the flag high for affordable drugs

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a growth of 17 percent in the year ending 2012. The domestic turnover incr...Read more

  • Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore

    Market Survey |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Theoretically, the synergy created between them spurs the company to bu...Read more

  • Dong-A Pharma diversifies portfolio to include biosimilars

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has built alliances with inte...Read more

  • Mindray Medical is set to penetrate the medtech market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing its product line with acquisitions that took place in 2012. The compa...Read more

  • Sino Biopharma banks on quality manufacturing

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chinese medicines and chemical medicines, has continued to be a quality o...Read more

  • Matt Kerr: Tough task ahead for APAC HR managers

    Market Survey |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, any period of extensive growth is often accompanied by growing pains, p...Read more

  • China Resources Sanjiu looks ahead at acquisitions for growth

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is adopting an acquisition strategy. It plans to acquire 97.18 percent s...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls